Arcellx Inc
ACLX
ISIN US03940C1009 / Valor 116080960
Arcellx Inc
UMushroom community rating:
About company
Arcellx Inc. is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer and other serious diseases. The company leverages its proprietary D-Domain technology to engineer novel, adaptive immune cell therapies designed to enhance the efficacy and safety of treatments. Arcellx's lead product candidates include CART-ddBCMA, a therapy targeting multiple myeloma, and other pipeline products aimed at various hematologic and solid tumor indications. The company is committed to advancing its clinical programs and expanding its therapeutic portfolio to address unmet medical needs in oncology.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
4192 M
Market cap (USD)
227,051
Daily traded volume (Shares)
82.9 / 78.03
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
